Tag: Interferon beta-1a

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Interferon beta-1a

MS Society Releases Guidance on DMT Dosing Modifications for COVID-19 Vaccination

Added to Collection on: 2021-02-19 22:07:30

Tags for this article:

Medical specialties
Medicine
Branches of biology
Clinical trials
Cytokines
Interferon beta-1a
Vaccine
N,N-Dimethyltryptamine
Multiple sclerosis
COVID-19 vaccine
Ozanimod
Multiple sclerosis drug pipeline
BioNTech

Click the tags to see associated articles and topics

View Article Details
How to Choose the Right RRMS Treatment for You

Added to Collection on: 2021-02-19 18:56:15

Tags for this article:

Cytokines
Medical specialties
Immunology
Drugs
Interferon beta-1a
Interferon beta-1b
Interferon
Glatiramer acetate
Multiple sclerosis drug pipeline
IFNB1

Click the tags to see associated articles and topics

View Article Details
Multiple Sclerosis Drugs Market to Register a Stout Growth by 2030 | Biogen, Novartis, Roche ...

Added to Collection on: 2021-04-11 20:26:15

Tags for this article:

Market structure
Health care
Economy
Health
Marketing strategy
Cytokines
Interferon beta-1a
Market
Merck & Co.
Pharmaceutical industry in China
Pharmaceutical industry in India
Competition

Click the tags to see associated articles and topics

View Article Details
Morgan Stanley Keeps a Buy Rating on Biogen (BIIB)

Added to Collection on: 2021-04-19 18:44:18

Tags for this article:

Life Sciences
Spinal muscular atrophy
Drugs
Health care
Orphan drugs
Biogen
Interferon beta-1a
Multiple sclerosis
Dimethyl fumarate
BioMarin Pharmaceutical
TipRanks
Nusinersen
BIOGEN , INC

Click the tags to see associated articles and topics

View Article Details
Multiple Sclerosis Drugs Market Size 2021-2028 | To Reach USD 41.99 Billion by 2028, Exhibiting ...

Added to Collection on: 2021-07-05 09:33:45

Tags for this article:

Medical specialties
Health care
Life Sciences
Monoclonal antibodies
Breakthrough therapy
Multiple sclerosis
Immunology
Autoimmune diseases
Management of multiple sclerosis
Biogen
Interferon beta-1a
Ocrelizumab

Click the tags to see associated articles and topics

View Article Details
Multiple Sclerosis Pipeline, FDA Approvals, Clinical Trials Development and Companies 2023

Added to Collection on: 2023-12-07 00:17:05

Tags for this article:

Multiple sclerosis
Biogen
Interferon beta-1a
Sanofi
Novartis
Cinnagen
Management of multiple sclerosis
Fingolimod
Bristol-Myers Squibb
Genentech
Multiple sclerosis research

Click the tags to see associated articles and topics

View Article Details
Hudson Bay Capital Management LP Reduces Position in Biogen Inc. (NASDAQ:BIIB)

Added to Collection on: 2023-12-11 19:12:19

Tags for this article:

Financial ratios
Corporate finance
Spinal muscular atrophy
Biogen
Equity securities
Fundamental analysis
Price?earnings ratio
Short
Stock
NeXT
Interferon beta-1a
Aducanumab
Biogen Inc.
Hudson Bay Capital Management Lp

Click the tags to see associated articles and topics

View Article Details
Clarius Group LLC Sells 350 Shares of Biogen Inc. (NASDAQ:BIIB) - Defense World

Added to Collection on: 2024-01-01 17:23:55

Tags for this article:

Spinal muscular atrophy
Biogen
Equity securities
Aducanumab
Stock
Short
Interferon beta-1a
Clarius Group LLC

Click the tags to see associated articles and topics

View Article Details
Spire Wealth Management Sells 99 Shares of Biogen Inc. (NASDAQ:BIIB) - Defense World

Added to Collection on: 2024-02-11 19:26:19

Tags for this article:

Spinal muscular atrophy
Biogen
Aducanumab
Interferon beta-1a
Biogen Inc.

Click the tags to see associated articles and topics

View Article Details
Biogen Inc. (NASDAQ:BIIB) Receives Average Rating of “Hold” from Brokerages

Added to Collection on: 2025-09-30 06:31:59

Tags for this article:

Equity securities
Stock market
Biogen
Spinal muscular atrophy
Interferon beta-1a
Share
Stock
Short
Aducanumab
Price?earnings ratio
Investment

Click the tags to see associated articles and topics

View Article Details
Book a Demo